OXFORD BIOMEDICA
Oxford BioMedica is a pioneer of gene and cell therapy, with a leading industry position in lentiviral vector and cell therapy research, development and manufacture. Gene therapy is the treatment of disease by delivering therapeutic DNA into a patient’s cells. This can be either in vivo or ex vivo, the latter encompassing the field of cell therapy whereby genetically modified cells are put back into the body. Their pipeline of seven gene and cell therapy therapy products addresses diseases for... which there is currently no treatment or that are inadequately treated today, including ocular and central nervous system disorders. Their product candidates have the potential to transform treatment landscapes. Their strategy is to develop their product candidates to their next value inflection points whilst continuing to build OXB Solutions into a valuable revenue-generating manufacturing and development services business.
OXFORD BIOMEDICA
Industry:
Biotechnology Genetics Therapeutics
Founded:
1995-01-01
Address:
Oxford, Oxfordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.oxb.com
Total Employee:
51+
Status:
Active
Contact:
+4401865783000
Email Addresses:
[email protected]
Total Funding:
62.3 M GBP
Technology used in webpage:
SPF Domain Not Resolving Google Maps Microsoft Azure DNS GoDaddy DNS Google Maps API Mimecast
Similar Organizations
4BIO Capital
4BIO Capital is a specialist fund focused on investing in and building early stage advanced therapy companies
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Amsterdam Scientific Instruments
Amsterdam Scientific Instruments specializes in the fields of neutron detection, electron imaging, and X-ray detector technology.
Arctos Medical
Arctos Medical is a developed gene therapy that does not correct rare genetic eye diseases but much more common cases of blindness.
arGEN-X
arGEN-X offers a platform for antibody lead choice that supports the discovery of human antibody therapeutics.
Batavia Biosciences
Batavia Biosciences focuses on accelerating the transition of biopharmaceutical product
BioCryst Pharmaceuticals
BioCryst has over 80 employees spread across their two locations in Birmingham, Alabama and Durham, North Carolina.
Celyad
Celyad is a provider of cell therapy treatments with an initial focus on cardiology and oncology.
Chameleon Biosciences
Chameleon Biosciences is transforming gene therapy with a re-dosable, AAV based gene therapy.
DNAdigest
DNAdigest is a scientific social enterprise that enables the secure sharing and query of genomics data for research.
EG 427
EG 427 is a French biotechnology company that pioneers a new approach in gene therapy called pinpoint gene therapy.
Enara Bio
Ervaxx is illuminating the immune interface to develop new cancer therapies.
Evaxion Biotech
Evaxion Biotech is devoted to the discovery and development of vaccines against cancer and infectious diseases.
Fulcrum Therapeutics
Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases.
Genetic Analysis
Genetic Analysis has the goal of being a leader within the field of molecular diagnostics of diseases related to gut imbalances.
Hookipa Pharma
Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.
Coave Therapeutics
Horama develops gene therapies for rare inherited ocular and CNS (central nervous system) diseases.
Horizon Discovery
Horizon is a gene editing company that designs & engineers genetically-modified cells, applying them to advance human health.
Hybrigenics
Hybrigenics offers a bioinformatics platforms to identify, validate, and inhibit protein interactions to develop therapeutics for cancer.
immatics biotechnologies
immatics is a biopharmaceutical company focused on the development of immunotherapeutic substances for cancer therapy.
Immunovia
Immunovia is the center for translational cancer research in Lund, Sweden.
Intima Biosciences
Intima Biosciences is a cell therapy business that focuses on solid tumor cancer cures.
Nouscom
Nouscom are a biotech company working to develop a series of new, potent immunotherapeutics capable of selectively killing tumor cells.
Oxford Nanopore Technologies
Oxford Nanopore Technologies develops nanopore-based electronic systems for analyzing single molecules, including DNA, RNA, and proteins.
Oxford Science Enterprises
Oxford Science Enterprises a university-partnered venture firm, investing in early-stage life science, AI & software, and deep tech.
Oxford Science Enterprises
Oxford Science Enterprises a university-partnered venture firm, investing in early-stage life science, AI & software, and deep tech.
Translate Bio
Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.
Reithera Srl
Reithera Srl is a company devoted to develop and produce biopharmaceutical products based on gene delivery technologies
Riboxx
Riboxx LIFE SCIENCES develops customized and tailor-made molecular tools for gene silencing in vitro and in vivo through RNA interference:
RoslinCT
RoslinCT is a UK Cell Therapy Contract Development and Manufacturing Organisation.
Sino-Biocan
Sino-Biocan focuses on the research and development of domestic tools in the field of cell and gene therapy.
T-knife
T-knife is a developer of T cell receptors intended for T cell therapy of cancer.
Xenothera
Xenothera is a xenotherapy platform with embedded technology that renovates immunological treatments.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2007-03-12 | Oxxon Therapeutics | Oxxon Therapeutics acquired by Oxford BioMedica | 16 M GBP |
Investors List
Serum Institute of India Pvt. Ltd.
Serum Institute of India Pvt. Ltd. investment in Post-IPO Equity - Oxford BioMedica
Innovate UK
Innovate UK investment in Grant - Oxford BioMedica
Official Site Inspections
http://www.oxb.com Semrush global rank: 496.53 K Semrush visits lastest month: 100.57 K
- Host name: 167.172.61.114
- IP address: 167.172.61.114
- Location: London United Kingdom
- Latitude: 51.5353
- Longitude: -0.6658
- Timezone: Europe/London
- Postal: SL1
